Kirkland & Ellis acted for GL Capital. Slaughter and May advised China International Capital Corporation Hong Kong Securities Limited (CICC) as financial adviser. Silver Pegasus Investment...
GL Capital’s $1.13 Billion Privatisation of Sciclone Pharmaceuticals
Panacea Venture’s $276 Million Fundraising
Kirkland & Ellis has advised Panacea Venture on the deal. Panacea Venture announced its second USD healthcare fund, which comprises of two vehicles, Panacea Venture Healthcare...
FountainVest’s Acquisition of Ziwi
Kirkland & Ellis acted as international counsel to FountainVest in the transaction. FountainVest, a leading private equity firm in China, finalized its acquisition of Ziwi, a...
Dayone Capital Fund I’s $630 Million Fundraising
Kirkland & Ellis advised Dayone Capital on the deal. Dayone Capital, a PRC-based PE sponsor focused on consumer sector, announced the fundraising and closing of its first...
Hosen Private Equity III’s $800 Million Fundraising
Kirkland & Ellis advised Hosen Capital on the deal. Hosen Capital (Hosen) completed the fundraising and final closing of its third USD fund at $800 million. The...
Ocean Link’s $580 Million Fundraising
Kirkland & Ellis advised Ocean Link on the deal. Ocean Link, a private equity firm with a focus on China’s fast-growing consumer, travel and TMT sectors,...
LAV Fund VI and LAV Fund VI Opportunities’ Fundraising
Kirkland advised Lilly Asia Ventures on the deal. Lilly Asia Ventures (LAV) completed the final closing of its sixth USD life sciences funds, LAV Fund VI, L.P. and...